Search
for
Sort by
Research 601–630 of 898
- The prostamide‐related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias
- Study of<i>Demodex</i>mites: Challenges and Solutions
- Hypertrichosis induced by latanoprost
- The History of Hair Transplantation
- Frontal fibrosing alopecia after antiandrogen hormonal therapy in a male patient
- Commentary
- Diagnosis: Alopecia areata or not?
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Estimation of health utility values for alopecia areata
- Chemotherapy‐induced alopecia – the urgent need for treatment options
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
- Diagnosis and management of hair loss in children
- Effectiveness of Baricitinib for Nasal, Genital, and Beard Hair Regrowth in Patients with Severe Alopecia Areata: 12-Month Outcomes from a Prospective Observational Study
- Mechanistic study of Erianin in alopecia areata
- 男性型脱毛症の原因についての手がかり
- Questions and answers for clinical insights
- Chronic Alopecia
- Reply
- Characteristics of 60 adult chronic hair pullers
- Anatomy and Physiology of the Skin
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Ubiquity and Diversity of Human-Associated Demodex Mites
- Diagnosis of hyperandrogenism: Biochemical criteria
- Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
- Long-Term Epilation Using the EpiLight Broad Band, Intense Pulsed Light Hair Removal System
- The Hair Follicle: A Paradoxical Androgen Target Organ
- Physiological Regeneration of Skin Appendages and Implications for Regenerative Medicine
- Dermatosurgical techniques for repigmentation of vitiligo
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Hair: What is New in Diagnosis and Management?